INSANE VALUE DIVIDEND STOCK PICK (I Bought Shares TODAY!)

Today I am buying more shares of this insane #value #dividend #stock pick. I'm, of course, talking about AbbVie (ABBV). Learn in today's video how I personally analyze dividend growth stocks. I'm not talking about a cursory look at the easy metrics. I'm talking about deep financial analysis via the company 10-Q (quarterly earnings report). PPC Ian is Dividend Investing For Everyone and today's video (and especially the stock analysis style) comes by popular request!

Timestamps:
0:00 Introduction
0:23 My investing track record. My dividend stock pick from one year ago, and its incredible performance.
1:31 I bought Starbucks (SBUX) at $48.14. I'm up 106% in just over 1 year.
2:49 I like to buy world class companies with great fundamentals when there is pessimism in the street. That is value investing!
3:52 I think there is an incredible value opportunity with AbbVie. I'm going to do this via AbbVie's 10-Q.
5:51 AbbVie is trading at $67.76 and I will probably buy more tomorrow (Monday).
6:54 AbbVie increased their adjusted EPS guidance!
7:38 ABBV forward 2019 PE is a 7.68 based on company guidance, placing it in value dividend stock territory.
8:18 Starting dividend yield is a solid 6.3%.
9:15 Dividend payout ratio is a conservative 48.5%.
10:21 Why is ABBV's PE ratio on Yahoo! Finance different than on PPC Ian? Let’s look at GAAP EPS vs. Adjusted EPS.
11:57 Q2 10-Q deep dive. This is the meat. Let's jump into the real numbers.
13:50 The GAAP results are inclusive of a non-cash charge (contingent consideration following regulatory approvals).
15:24 FDA and EC approved Skyrizi!
16:32 Contingent consideration is an "earn out".
19:00 We want them to take this charge. This new drug got approved and will generate revenue for shareholders like myself.
20:44 AbbVie will get royalties from BI.
23:42 AbbVie stock is really down due to Humira. Here's why. Let's do a worst case analysis.
26:30 I believe that PE of AbbVie goes to 11 in a worst case scenario (even if half of Humira sales are lost and Allergan acquisition does not go through). Payout ratio is 70% - still doable.
27:55 There are risks with this stock.
28:55 A lot of investors buy at the complete wrong time!
30:12 I have really exciting news for the community!

As mentioned in today's video, here's my brand new PPC Ian Facebook Group:   / 358099944830257  

Want to follow along at home? Here's a link to AbbVie's (ABBV) financial reports: https://investors.abbvie.com/financia...

Want to watch my video from a year ago when I was buying Starbucks (SBUX) stock on the cheap? Check it out:    • I'M BUYING THIS DIVIDEND STOCK IMMEDIATELY...  

Here's my complete dividend stock portfolio:    • Download My Updated Dividend Stock Portfolio  

Here's my in-depth ABBV dividend stock analysis:    • ALERT: I'M BUYING THIS DIVIDEND VALUE STOC...  

Here is my video about stock market brokers:    • Stock Brokers For Dividend Investors: How ...  

Here is my video about dividend reinvestment plans:    • How To Invest In Dividend Stocks With DRIP...  

DISCLOSURE: I am long Starbucks (SBUX), AbbVie (ABBV), and 3M (MMM). I own these stocks in my stock portfolio.

DISCLAIMER: All information and data on my YouTube Channel, blog, email newsletters, white papers, Excel files, and other materials is solely for informational purposes. I make no representations as to the accuracy, completeness, suitability or validity of any information. I will not be liable for any errors, omissions, losses, injuries or damages arising from its display or use. All information is provided AS IS with no warranties, and confers no rights. I will not be responsible for the accuracy of material that is linked on this site.

Because the information herein is based on my personal opinion and experience, it should not be considered professional financial investment advice or tax advice. The ideas and strategies that I provide should never be used without first assessing your own personal/financial situation, or without consulting a financial and/or tax professional. My thoughts and opinions may also change from time to time as I acquire more knowledge. These are, as discussed above, solely my thoughts and opinions. I reserve the right to delete any comments for any reason (abusive in nature, contain profanity, etc.). Your continued reading/use of my YouTube Channel, blog, email newsletters, whitepapers, Excel files, and other materials constitutes your agreement with and acceptance of this disclaimer.

COPYRIGHT: All PPC Ian videos, Excel files, guides, and other content are (c) Copyright IJL Productions LLC. PPC Ian is a registered trademark (tm) of IJL Productions LLC.